Salarius Pharmaceuticals ...
2.57
-0.07 (-2.65%)
At close: Jan 15, 2025, 2:34 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue n/a n/a 1.84M 5.23M 3.47M 838.00K 1.27M 1.01M n/a
Cost of Revenue 10.05K 6.68K 19.18K 6.91K 4.02K 431.00K 507.00K 663.00K 49.88K
Gross Profit -10.05K -6.68K 1.82M 5.23M 3.46M 407.00K 768.00K 348.00K -49.88K
Operating Income -12.89K -31.84M -12.81M -7.79M -9.58M -22.07M -34.73M -39.89M -29.21M
Interest Income 352.25K 218.73 n/a n/a 15.65K n/a n/a n/a n/a
Pretax Income -12.54K -31.61M -12.77M -7.35M -6.94M -21.92M -34.43M -39.49M -29.14M
Net Income -12.54K -31.37M -12.70M -7.10M -5.61M -21.92M -34.43M -39.49M -29.14M
Selling & General & Admin 5.72K 7.14M 6.10M 6.11M 7.71M 10.57M 18.50M 19.86M 16.46M
Research & Development 7.17K 15.84M 8.55M 6.91M 4.02M 11.91M 16.99M 20.38M 12.75M
Other Expenses n/a 8.87M -4 -178.59K n/a n/a n/a n/a n/a
Operating Expenses 12.89K 22.98M 14.65M 12.84M 11.73M 22.48M 35.49M 40.23M 29.21M
Interest Expense n/a n/a n/a 3.05K n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a 8.22M 17.14M 19.06M n/a
Cost & Expenses 12.89K 22.98M 14.65M 12.84M 11.73M 22.91M 36.00M 40.90M 29.21M
Income Tax n/a -233.18K -63.88K -255.50K -1.33M 152.01K -324.58K -277.12K -49.85K
Shares Outstanding (Basic) 3.26M 2.12M 1.65M 623.14K 130.75K 28.83K 27.62K 25.97K 22.45K
Shares Outstanding (Diluted) 3.26M 2.12M 1.65M 623.14K 130.75K 28.83K 27.62K 25.97K 22.45K
EPS (Basic) -0.00 -14.77 -7.68 -11.39 -42.9 -760.47 -1.25K -1.52K -1.30K
EPS (Diluted) -0.00 -14.77 -7.68 -11.39 -42.9 -760.47 -1.25K -1.52K -1.30K
EBITDA -12.88K -31.60M -12.75M -7.33M -6.92M -22.07M -34.11M -39.89M -29.09M
Depreciation & Amortization 10.05K 6.68K 19.18K 18.06K 16.93K 16.95K 324.55K 277.23K 49.88K

Create Price Alert on SLRX

Your price alert will notify you when the stock price is above 2.57.

Add to Watchlist